VREOF

Vireo Growth Inc.

OTC · CIK 1771706

Last close9.49
Daily change-0.36 (-3.65%)
10 Years gain-93.03%
Dividends TTM0
Dividend yield0.00%

Fundamental Analysis

VREOF · STANDARD

SIC 2834 · Pharmaceutical Preparations · Fiscal year end 1231

Screener
Fundamental
71.1
Momentum
0.0
Acceleration
0.0
Confidence
83.0
Annual Revenue6
Quarterly Revenue20
Annual CFO6
Balance SheetAvailable
RankingEligible

Score Breakdown

Growth19.1 / 25
Quality18.7 / 25
Capital Efficiency7.8 / 20
Balance Sheet12.1 / 15
Shareholder Economics8.5 / 10
Forward Indicators5.0 / 5

Signals

Net debt reductionNet debt declined versus the comparison period.
Share count reductionDiluted share count declined 87.7081%.

Warnings

Inventory anomaly · MEDIUMInventory growth is materially above revenue growth.
Gross margin compression · MEDIUMGross margin compressed by 4.4497 percentage points.
Operating margin compression · MEDIUMOperating margin compressed by 16.2625 percentage points.
Possible growth trap · HIGHRevenue growth is high, but quality indicators are deteriorating.

Key Metrics

Revenue Growth TTM360.5%OK
Revenue CAGR 3Y53.28%OK
Gross Margin46.65%OK
Operating Margin0.33%OK
FCF Marginn/aMISSING
FCF Growthn/aINSUFFICIENT_HISTORY
ROIC0.84%OK
Incremental Operating Margin 3Y4.18%OK
Net Debt / CFOn/aNOT_MEANINGFUL
Diluted Share Growth 1Y-87.71%OK
SBC / Revenue4.94%OK
SBC / FCFn/aNOT_MEANINGFUL

Financial History

PeriodRevenueGross ProfitOperating IncomeCFOFCFGross MarginOp MarginFCF MarginROICShares
2025 FY Dec 31, 2025$268.77M$127.10M-$1.05M$3.71M-$24.61M47.29%-0.39%-9.16%-1.12%734.74M
2025 FY Dec 31, 2024$99.38M$50.77M$13.56M-$10.23M-$21.93M51.09%13.65%-22.07%n/a180.39M
2024 FY Dec 31, 2023$88.13M$44.10M$10.58M-$965,906.00-$5.93M50.04%12%-6.73%116.8%135.24M
2023 FY Dec 31, 2022$74.63M$30.91M-$6.94M-$18.07M-$23.63M41.42%-9.3%-31.67%-10.8%128.13M
2022 FY Dec 31, 2021$54.45M$19.80M-$20.48M-$30.52M-$48.56M36.36%-37.62%-89.19%-35.35%123.81M

Formula Trace

MetricValueFormulaStatusSource
Revenue TTM$455.26Msum latest 4 fiscal quarters RevenueOK0001104659-26-097118, 0001104659-25-110364
Revenue Growth TTM360.5%Revenue_TTM / Revenue_TTM_1Y_ago - 1OK0001104659-26-097118, 0001104659-25-110364
Revenue CAGR 3Y53.28%(Revenue_current / Revenue_3Y_ago)^(1/3) - 1OK0001104659-26-029561
Revenue CAGR 5Y40.43%(Revenue_current / Revenue_5Y_ago)^(1/5) - 1OK0001104659-26-029561
Gross Profit CAGR 3Y60.21%(GrossProfit_current / GrossProfit_3Y_ago)^(1/3) - 1OK0001104659-26-029561
Operating Income Growth-90.8%OperatingIncome_current / OperatingIncome_prior_year - 1OK0001104659-26-097118, 0001104659-25-110364
FCF Growthn/aFCF_current / FCF_prior_year - 1INSUFFICIENT_HISTORYderived
Revenue Growth Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Gross Profit Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Operating Income Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
FCF Accelerationn/a0.5*(Q0-Q1)+0.3*(Q1-Q2)+0.2*(Q2-Q3)INSUFFICIENT_HISTORYderived
Gross Margin46.65%Gross Profit / RevenueOK0001104659-26-097118, 0001104659-25-110364
Operating Margin0.33%Operating Income / RevenueOK0001104659-26-097118, 0001104659-25-110364
ROIC0.84%NOPAT / Average Invested CapitalOK0001104659-26-097118, 0001104659-25-110364
Net Debt / CFOn/aNet Debt / CFONOT_MEANINGFUL0001104659-26-097118
Current Ratio1.01xCurrent Assets / Current LiabilitiesOKderived
SBC / Revenue4.94%SBC / RevenueOK0001104659-26-097118, 0001104659-26-059455
Revenue per Diluted Share$10.10Revenue / Diluted SharesOK0001104659-26-097118, 0001104659-25-110364